Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 3402809, 17 pages
https://doi.org/10.1155/2018/3402809
Research Article

Hydrogen Sulfide Alleviates Acute Myocardial Ischemia Injury by Modulating Autophagy and Inflammation Response under Oxidative Stress

1Shanghai Key Laboratory of Bioactive Small Molecules, Shanghai Key Laboratory of Clinical Geriatric Medicine, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China
2Key Laboratory of Molecular Virology and Immunology, Vaccine Center, Institute Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China
3Department of Physiology, Hebei Medical University, Hebei 050017, China

Correspondence should be addressed to Ming-jie Wang; nc.ude.umhs@gnawjm and Yi-chun Zhu; nc.ude.umhs@uhzcy

Received 28 December 2017; Revised 1 April 2018; Accepted 17 April 2018; Published 1 August 2018

Academic Editor: Liang-Jun Yan

Copyright © 2018 Ya-dan Bai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Dalen, J. S. Alpert, R. J. Goldberg, and R. S. Weinstein, “The epidemic of the 20th century: coronary heart disease,” The American Journal of Medicine, vol. 127, no. 9, pp. 807–812, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Zhao, Z. Zhang, Q. Long et al., “Association between time of day of sports-related physical activity and the onset of acute myocardial infarction in a Chinese population,” PLoS One, vol. 11, no. 1, article e0146472, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Deng, Y. Xia, M. Fu et al., “Influence of heart failure on the prognosis of patients with acute myocardial infarction in southwestern China,” Experimental and Therapeutic Medicine, vol. 11, no. 6, pp. 2127–2138, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. S. E. Nissen and K. Wolski, “Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes,” New England Journal of Medicine, vol. 356, no. 24, pp. 2457–2471, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Skyschally, R. Schulz, and G. Heusch, “Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning,” Herz Kardiovaskuläre Erkrankungen, vol. 33, no. 2, pp. 88–100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. I. Brown and K. K. Griendling, “Regulation of signal transduction by reactive oxygen species in the cardiovascular system,” Circulation Research, vol. 116, no. 3, pp. 531–549, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. S. V. Lakshmi, G. Padmaja, P. Kuppusamy, and V. K. Kutala, “Oxidative stress in cardiovascular disease,” Indian Journal of Biochemistry & Biophysics, vol. 46, no. 6, pp. 421–440, 2009. View at Google Scholar
  8. G. Rosano, M. Fini, G. Caminiti, and G. Barbaro, “Cardiac metabolism in myocardial ischemia,” Current Pharmaceutical Design, vol. 14, no. 25, pp. 2551–2562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. O. S. Kornfeld, S. Hwang, M. H. Disatnik, C. H. Chen, N. Qvit, and D. Mochly-Rosen, “Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases,” Circulation Research, vol. 116, no. 11, pp. 1783–1799, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Rochette, J. Lorin, M. Zeller et al., “Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?” Pharmacology & Therapeutics, vol. 140, no. 3, pp. 239–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Miao and D. K. St. Clair, “Regulation of superoxide dismutase genes: implications in disease,” Free Radical Biology and Medicine, vol. 47, no. 4, pp. 344–356, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. G. K. Asimakis, S. Lick, and C. Patterson, “Postischemic recovery of contractile function is impaired in SOD2+/− but not SOD1+/− mouse hearts,” Circulation, vol. 105, no. 8, pp. 981–986, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Freitas, N. Brucker, J. Durgante et al., “Urinary 1-hydroxypyrene is associated with oxidative stress and inflammatory biomarkers in acute myocardial infarction,” International Journal of Environmental Research and Public Health, vol. 11, no. 9, pp. 9024–9037, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. K. Daga, M. Chaudhary, B. Sharma et al., “Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction,” Journal of the Association of Physicians of India, vol. 51, pp. 677–680, 2003. View at Google Scholar
  15. D. Simic, J. Mimic-Oka, M. Plješa et al., “Time course of erythrocyte antioxidant activity in patients treated by thrombolysis for acute myocardial infarction,” Japanese Heart Journal, vol. 44, no. 6, pp. 823–832, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Chen, B. Siu, Y. S. Ho et al., “Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice,” Journal of Molecular and Cellular Cardiology, vol. 30, no. 11, pp. 2281–2289, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Wang, H. Chen, H. Qin et al., “Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 8, pp. 4556–4560, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. E. L. Eskelinen and P. Saftig, “Autophagy: a lysosomal degradation pathway with a central role in health and disease,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1793, no. 4, pp. 664–673, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Sridhar, Y. Botbol, F. Macian, and A. M. Cuervo, “Autophagy and disease: always two sides to a problem,” The Journal of Pathology, vol. 226, no. 2, pp. 255–273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Lavandero, M. Chiong, B. A. Rothermel, and J. A. Hill, “Autophagy in cardiovascular biology,” Journal of Clinical Investigation, vol. 125, no. 1, pp. 55–64, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Nakai, O. Yamaguchi, T. Takeda et al., “The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress,” Nature Medicine, vol. 13, no. 5, pp. 619–624, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. G. Gutierrez, S. S. Master, S. B. Singh, G. A. Taylor, M. I. Colombo, and V. Deretic, “Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages,” Cell, vol. 119, no. 6, pp. 753–766, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Hara, K. Nakamura, M. Matsui et al., “Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice,” Nature, vol. 441, no. 7095, pp. 885–889, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. D. J. Klionsky and S. D. Emr, “Autophagy as a regulated pathway of cellular degradation,” Science, vol. 290, no. 5497, pp. 1717–1721, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Qu, J. Yu, G. Bhagat et al., “Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1809–1820, 2003. View at Publisher · View at Google Scholar
  26. Y. Matsui, H. Takagi, X. Qu et al., “Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy,” Circulation Research, vol. 100, no. 6, pp. 914–922, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Yan, D. E. Vatner, S. J. Kim et al., “Autophagy in chronically ischemic myocardium,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 39, pp. 13807–13812, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Zhu, P. Tannous, J. L. Johnstone et al., “Cardiac autophagy is a maladaptive response to hemodynamic stress,” Journal of Clinical Investigation, vol. 117, no. 7, pp. 1782–1793, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Murphy and C. Steenbergen, “Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury,” Physiological Reviews, vol. 88, no. 2, pp. 581–609, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. N. G. Frangogiannis, “The inflammatory response in myocardial injury, repair, and remodelling,” Nature Reviews Cardiology, vol. 11, no. 5, pp. 255–265, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Yokoyama, L. Vaca, R. D. Rossen, W. Durante, P. Hazarika, and D. L. Mann, “Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart,” Journal of Clinical Investigation, vol. 92, no. 5, pp. 2303–2312, 1993. View at Publisher · View at Google Scholar
  32. N. G. Frangogiannis, “Regulation of the inflammatory response in cardiac repair,” Circulation Research, vol. 110, no. 1, pp. 159–173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Nahrendorf, M. J. Pittet, and F. K. Swirski, “Monocytes: protagonists of infarct inflammation and repair after myocardial infarction,” Circulation, vol. 121, no. 22, pp. 2437–2445, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. D. Prabhu and N. G. Frangogiannis, “The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis,” Circulation Research, vol. 119, no. 1, pp. 91–112, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Hosoki, N. Matsuki, and H. Kimura, “The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide,” Biochemical and Biophysical Research Communications, vol. 237, no. 3, pp. 527–531, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Zhao, J. Zhang, Y. Lu, and R. Wang, “The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener,” The EMBO Journal, vol. 20, no. 21, pp. 6008–6016, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Cai, M. Wang, P. Moore, H. Jin, T. Yao, and Y. Zhu, “The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation,” Cardiovascular Research, vol. 76, no. 1, pp. 29–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. B. B. Tao, S. Y. Liu, C. C. Zhang et al., “VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045–Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells,” Antioxidants & Redox Signaling, vol. 19, no. 5, pp. 448–464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. M. J. Wang, W. J. Cai, N. Li, Y. J. Ding, Y. Chen, and Y. C. Zhu, “The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia,” Antioxidants & Redox Signaling, vol. 12, no. 9, pp. 1065–1077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. W. H. Sun, F. Liu, Y. Chen, and Y. C. Zhu, “Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion,” Biochemical and Biophysical Research Communications, vol. 421, no. 2, pp. 164–169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. J. S. Bian, Q. C. Yong, T. T. Pan et al., “Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes,” Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 2, pp. 670–678, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. L. L. Yao, X. W. Huang, Y. G. Wang, Y. X. Cao, C. C. Zhang, and Y. C. Zhu, “Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3β-dependent opening of mPTP,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 298, no. 5, pp. H1310–H1319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Li, M.-J. Wang, S. Jin et al., “The H2S donor NaHS changes the expression pattern of H2S-producing enzymes after myocardial infarction,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 6492469, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. J. A. Riquelme, M. N. Chavez, D. Mondaca-Ruff et al., “Therapeutic targeting of autophagy in myocardial infarction and heart failure,” Expert Review of Cardiovascular Therapy, vol. 14, no. 9, pp. 1007–1019, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Meley, C. Bauvy, J. H. P. M. Houben-Weerts et al., “AMP-activated protein kinase and the regulation of autophagic proteolysis,” Journal of Biological Chemistry, vol. 281, no. 46, pp. 34870–34879, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. L. B. Becker, “New concepts in reactive oxygen species and cardiovascular reperfusion physiology,” Cardiovascular Research, vol. 61, no. 3, pp. 461–470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. L. G. Kevin, A. K. S. Camara, M. L. Riess, E. Novalija, and D. F. Stowe, “Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 284, no. 2, pp. H566–H574, 2003. View at Publisher · View at Google Scholar
  48. J. M. Gump and A. Thorburn, “Autophagy and apoptosis: what is the connection?” Trends in Cell Biology, vol. 21, no. 7, pp. 387–392, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. S. B. Ong, S. Hernández-Reséndiz, G. E. Crespo-Avilan et al., “Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities,” Pharmacology & Therapeutics, vol. 186, pp. 73–87, 2018. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Teringova and P. Tousek, “Apoptosis in ischemic heart disease,” Journal of Translational Medicine, vol. 15, no. 1, p. 87, 2017. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Hristov and C. Weber, “Myocardial infarction and inflammation: lost in the biomarker labyrinth,” Circulation Research, vol. 116, no. 5, pp. 781–783, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. S. R. Umansky, J. P. Shapiro, G. M. Cuenco, M. W. Foehr, I. C. Bathurst, and L. D. Tomei, “Prevention of rat neonatal cardiomyocyte apoptosis induced by simulated in vitro ischemia and reperfusion,” Cell Death and Differentiation, vol. 4, no. 7, pp. 608–616, 1997. View at Publisher · View at Google Scholar
  53. D. A. Kubli and A. B. Gustafsson, “Cardiomyocyte health: adapting to metabolic changes through autophagy,” Trends in Endocrinology & Metabolism, vol. 25, no. 3, pp. 156–164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Scherz-Shouval, E. Shvets, E. Fass, H. Shorer, L. Gil, and Z. Elazar, “Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4,” The EMBO Journal, vol. 26, no. 7, pp. 1749–1760, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Tang, R. Kang, K. M. Livesey, H. J. Zeh III, and M. T. Lotze, “High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress,” Antioxidants & Redox Signaling, vol. 15, no. 8, pp. 2185–2195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Jiang, J. Xiao, B. Kang, X. Zhu, N. Xin, and Z. Wang, “PI3K/SGK1/GSK3β signaling pathway is involved in inhibition of autophagy in neonatal rat cardiomyocytes exposed to hypoxia/reoxygenation by hydrogen sulfide,” Experimental Cell Research, vol. 345, no. 2, pp. 134–140, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Xiao, X. Zhu, B. Kang et al., “Hydrogen sulfide attenuates myocardial hypoxia-reoxygenation injury by inhibiting autophagy via mTOR activation,” Cellular Physiology and Biochemistry, vol. 37, no. 6, pp. 2444–2453, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Xie, Q. Xu, J. Jia et al., “Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux,” Biochemical and Biophysical Research Communications, vol. 458, no. 3, pp. 632–638, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Zhang, H. Li, G. Zhao et al., “Hydrogen sulfide attenuates the recruitment of CD11b+Gr-1+ myeloid cells and regulates Bax/Bcl-2 signaling in myocardial ischemia injury,” Scientific Reports, vol. 4, no. 1, article 4774, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Bhatia, “H2S and inflammation: an overview,” in Chemistry, Biochemistry and Pharmacology of Hydrogen Sulfide, vol. 230 of Handbook of Experimental Pharmacology, pp. 165–180, Springer, Cham, 2015. View at Publisher · View at Google Scholar · View at Scopus